Cognitive stimulation therapy for nursing home residents with dementia
Cognitive Stimulation Therapy for Residents With Dementia in Skilled Nursing Facilities: A Randomized Controlled Trial
NA · Northern Kentucky University · NCT06978972
This study is testing if cognitive stimulation therapy can help nursing home residents with mild-to-moderate dementia think better and engage more in activities compared to regular care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Northern Kentucky University (other) |
| Locations | 1 site (Lawrenceburg, Indiana) |
| Trial ID | NCT06978972 on ClinicalTrials.gov |
What this trial studies
This experimental study aims to evaluate the effectiveness of cognitive stimulation therapy (CST) in improving cognitive functioning and engagement among individuals with mild-to-moderate dementia residing in skilled nursing facilities. It is a double-blind, randomized controlled trial comparing CST, which includes themed group sessions and various cognitive activities, to maintenance-level care. The study will enroll approximately 10 participants over a period of 1-2 months at Ridgewood Health Campus in Indiana, with recruitment facilitated by site staff. Participants will be randomly assigned to either the CST group or the control group receiving standard care.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 18 and older with a diagnosis of mild-to-moderate dementia living in long-term care facilities.
Not a fit: Patients who have previously received cognitive stimulation therapy or are currently in hospice care may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could enhance cognitive functioning and engagement for patients with dementia, improving their quality of life.
How similar studies have performed: Previous studies have shown positive outcomes with cognitive stimulation therapy in similar populations, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provide informed consent * Diagnosis of mild-to-moderate dementia according to the DSM-V as determined by a score of 10-25 on the MoCA * Living in a long-term care facility * Engaging in at least 45 minutes a week of recreational or social activities * Aged 18 years or older * Adequate English proficiency, vision, hearing, and speech to participate in groups * Sufficient ability in communication to participate in assessments and CST sessions * Scores in mid-range on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) Exclusion Criteria: * Prior CST treatment * History of a learning disability or traumatic brain injury * Participation in a concurrent clinical trial * Receiving hospice care * Scores in high-range on the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog)
Where this trial is running
Lawrenceburg, Indiana
- Ridgewood Health Campus — Lawrenceburg, Indiana, United States (RECRUITING)
Study contacts
- Study coordinator: Abigail G Halsey, Doctor of occupational therapy
- Email: halseya2@nku.edu
- Phone: 937-781-6940
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Dementia in Nursing Home, Skilled nursing facilities, occupational engagement, cognitive functioning, Cognitive stimulation therapy, dementia, Group intervention, long-term care